By Counterforce Health Team in Cosentyx (secukinumab) —

Do You Qualify for Cosentyx Coverage by Cigna in Virginia? Complete Decision Tree & Appeal Guide

Answer Box: Your Path to Cosentyx Coverage

Yes, you can get Cosentyx (secukinumab) covered by Cigna in Virginia if you meet specific criteria. The fastest path: confirm your diagnosis qualifies (moderate-to-severe plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis), complete tuberculosis screening, and document failed trials of preferred agents like Humira or Enbrel. Submit your prior authorization through CoverMyMeds or your provider's portal within 72 hours for standard review. If denied, Virginia's Bureau of Insurance offers free external review within 120 days.

Start today: Call your dermatologist or rheumatologist to request TB screening and gather documentation of previous treatment failures.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Triage: Do You Qualify?
  3. If You're "Likely Eligible": Document Checklist
  4. If You're "Possibly Eligible": Tests to Request
  5. If You're "Not Yet Eligible": Alternative Options
  6. If You're Denied: Virginia Appeals Process
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & Solutions
  9. FAQ: Cosentyx Coverage in Virginia

How to Use This Guide

This decision tree helps Virginia residents navigate Cigna's prior authorization process for Cosentyx (secukinumab). Work through each section in order—from eligibility through appeals—to find your specific pathway to coverage.

Important: This guide reflects Cigna's requirements as managed through Express Scripts/Accredo specialty pharmacy. Your specific plan may have variations, so always verify current requirements with your provider.

Eligibility Triage: Do You Qualify?

Step 1: Diagnosis Confirmation

You're likely eligible if you have:

  • Moderate-to-severe plaque psoriasis (≥3% body surface area OR affecting hands, feet, face, neck, scalp, or genitals)
  • Active psoriatic arthritis (with or without skin involvement)
  • Active ankylosing spondylitis
  • Non-radiographic axial spondyloarthritis
  • Hidradenitis suppurativa (moderate-to-severe)

Age requirements: 6+ years for psoriasis, 2+ years for psoriatic arthritis, adults for ankylosing spondylitis.

Step 2: Specialist Involvement

Required: Prescription from dermatology or rheumatology specialist. Primary care physicians typically cannot initiate Cosentyx prior authorization with Cigna.

Step 3: Prior Therapy Requirements

Step therapy typically required:

  • Traditional systemic agents (≥3 months): methotrexate, cyclosporine, or acitretin
  • Preferred TNF inhibitors: adalimumab (Humira), etanercept (Enbrel), or infliximab products

Medical exceptions possible for:

  • Contraindications to required agents
  • Secondary loss of efficacy
  • Intolerable side effects

Step 4: Required Screening

Tuberculosis screening mandatory:

  • QuantiFERON-TB Gold or tuberculin skin test (TST) within 6-12 months
  • Chest X-ray if TB test is positive
  • Complete LTBI treatment (3-4 weeks minimum) before starting Cosentyx if positive

If You're "Likely Eligible": Document Checklist

Essential Documents to Gather

Clinical Documentation:

  • Specialist consultation notes confirming diagnosis
  • PASI scores (for psoriasis) or inflammatory markers
  • Body surface area measurements or photos of affected areas
  • Treatment history with specific drug names, doses, dates, and outcomes

Required Screening:

  • TB screening results (QuantiFERON or TST) within 6-12 months
  • Chest X-ray report
  • LTBI treatment completion documentation (if applicable)

Insurance Information:

  • Cigna member ID and policy details
  • Prior authorization form completion
  • Prescriber attestation of medical necessity

Submission Process

Fastest path: Submit through CoverMyMeds or your provider's EHR system.

Alternative methods:

  • Fax to (855) 840-1678
  • Online via Express Scripts/Accredo provider portals
  • Call (800) 882-4462 for urgent requests

Timeline: 72 hours for complete submissions; 5 business days for standard prescription drug requests.

If You're "Possibly Eligible": Tests to Request

Additional Documentation Needed

For borderline severity:

  • Quality of life assessments (DLQI scores)
  • Photography of affected areas
  • Detailed symptom diary
  • Work or activity limitations documentation

For step therapy exceptions:

  • Allergy testing results
  • Documentation of specific adverse events
  • Genetic testing (if relevant for drug metabolism)
  • Specialist letter explaining contraindications

Timeline to Re-apply

Wait 30-60 days after gathering additional documentation before resubmitting. Use this time to:

  • Complete any missing screening tests
  • Document response (or lack thereof) to current treatments
  • Obtain additional specialist opinions if needed

If You're "Not Yet Eligible": Alternative Options

Immediate Alternatives to Discuss

Other IL-17 inhibitors:

  • Taltz (ixekizumab) - may have different step therapy requirements
  • Skyrizi (risankizumab) - IL-23 inhibitor with potentially easier approval

TNF inhibitors to try first:

  • Humira (adalimumab) or biosimilars
  • Enbrel (etanercept) or biosimilars
  • Remicade (infliximab) or biosimilars

Preparing for Future Exception Requests

Document everything:

  • Reasons why preferred agents won't work
  • Genetic factors affecting drug metabolism
  • Comorbidities that complicate treatment choices
  • Quality of life impact requiring specific therapy

Build your case:

  • Gather peer-reviewed literature supporting Cosentyx for your specific situation
  • Obtain multiple specialist opinions
  • Consider clinical trial participation if available

If You're Denied: Virginia Appeals Process

Level 1: Internal Appeal with Cigna

Timeline: File within 180 days of denial notice Process: Submit additional clinical documentation and specialist letter Decision time: 15-30 days for standard appeals

Level 2: Peer-to-Peer Review

Request: Your prescriber can request a clinical discussion with Cigna's medical director Preparation: Gather latest treatment guidelines and patient-specific factors Outcome: May result in immediate approval or modified coverage

Level 3: Virginia External Review

Virginia offers robust external review protections through the State Corporation Commission's Bureau of Insurance.

Eligibility: After completing Cigna's internal appeals process Timeline: Submit within 120 days of final denial Cost: Free to patients Decision time: 45 days for standard review, 72 hours for expedited

How to file:

  1. Complete External Review Request Form 216-A (verify current form)
  2. Include all medical records and denial letters
  3. Submit to Virginia Bureau of Insurance
  4. Contact (877) 310-6560 for guidance

Expedited review available if:

  • Delay could seriously jeopardize your health
  • Doctor certifies urgency
  • Decision within 72 hours
From our advocates: We've seen many Virginia patients succeed with external review by focusing on the gap between Cigna's denial reasoning and current treatment guidelines. One key is having your specialist write a detailed letter explaining why the denied medication is specifically necessary for your case, not just generally effective for your condition.

Coverage Requirements at a Glance

Requirement Details Where to Find
Prior Authorization Required for all formulations Cigna PA Policy CNF-432
Formulary Status Specialty tier (Step 1) Express Scripts formulary
Step Therapy TNF inhibitor trial required Cigna medical policy
Quantity Limits 30-day supply for self-injectable Accredo specialty pharmacy
Site of Care Home/office for SC; outpatient for IV Coverage policy
Age Restrictions 6+ years psoriasis, 2+ years PsA FDA labeling
TB Screening QuantiFERON or TST within 6-12 months Medical necessity requirements
Appeals Deadline 180 days internal, 120 days external Virginia insurance code

Common Denial Reasons & Solutions

Denial Reason How to Overturn
Missing step therapy Submit documentation of Humira/Enbrel trial with dates, doses, and outcomes
Insufficient TB screening Provide QuantiFERON results and chest X-ray within required timeframe
Not medically necessary Request peer-to-peer review with updated PASI scores and quality of life measures
Non-formulary File formulary exception with contraindications to preferred alternatives
Quantity exceeded Provide dosing rationale based on FDA labeling and specialist recommendation
Wrong site of care Clarify self-injectable vs. IV formulation requirements

FAQ: Cosentyx Coverage in Virginia

How long does Cigna prior authorization take in Virginia? Standard PA decisions take 72 hours with complete documentation or 5 business days for prescription drug requests. Expedited reviews are completed within 24 hours if health is at risk.

What if Cosentyx is non-formulary on my plan? You can request a formulary exception by demonstrating contraindications or inadequate response to preferred alternatives. This requires detailed clinical documentation and specialist support.

Can I request an expedited appeal in Virginia? Yes, Virginia law allows expedited external review within 72 hours if your doctor certifies that waiting could seriously harm your health or ability to function.

Does step therapy apply if I failed these drugs outside Virginia? Yes, documented treatment failures from other states count toward step therapy requirements, provided you have adequate medical records showing drug names, doses, duration, and reasons for discontinuation.

What's the difference between Cigna's internal appeal and Virginia's external review? Internal appeals are decided by Cigna's medical staff, while external review involves an independent medical expert assigned by Virginia's Bureau of Insurance. External review decisions are binding on Cigna.

How much will Cosentyx cost with Cigna coverage? Specialty tier medications typically have 20-40% coinsurance after deductible. Novartis offers copay assistance that may reduce out-of-pocket costs to $5 per month for eligible patients.

Counterforce Health helps patients navigate complex prior authorization processes by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, identifies specific coverage criteria, and drafts point-by-point rebuttals using the right clinical evidence and payer-specific requirements. Whether you're facing step therapy hurdles or medical necessity challenges, Counterforce Health provides the tools and expertise to improve your chances of coverage approval.

If you're struggling with a Cosentyx denial in Virginia, consider leveraging technology and advocacy resources that understand both Cigna's specific requirements and Virginia's consumer protection laws. The combination of proper documentation, clinical evidence, and knowledge of your appeal rights can make the difference between paying full price and getting the coverage you deserve.

Remember: Virginia's external review process has helped many patients overturn wrongful denials. Don't give up after an initial "no"—the state's independent review system exists specifically to ensure patients receive medically necessary treatments.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage varies by plan and individual circumstances. Always consult with your healthcare provider and insurance company for personalized guidance. For assistance with appeals or coverage questions in Virginia, contact the State Corporation Commission's Bureau of Insurance at (877) 310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.